Evaluation and Clinical Management of Alzheimer's Disease - Blake Finn - Books - Foster Academics - 9781632427885 - June 24, 2019
In case cover and title do not match, the title is correct

Evaluation and Clinical Management of Alzheimer's Disease

Blake Finn

Price
Ft 44,041
excl. VAT

Ordered from remote warehouse

Expected delivery Sep 19 - 30
Add to your iMusic wish list

Evaluation and Clinical Management of Alzheimer's Disease

AlzheimerÂ’s disease is a chronic neurodegenerative disease. Usually it begins slowly, but worsens with the passage of time. In most of the cases, it is the cause of dementia, i.e., a decrease in the ability to think and remember. Symptoms of AlzheimerÂ’s disease include short-term memory loss, mood swings, disorientation, problems with language and inability to manage self. The causes of AlzheimerÂ’s disease are found to be genetic in most of the cases. Cognitive testing with medical imaging and blood tests is often used for the purpose of diagnosis. There is no known cure for AlzheimerÂ’s disease. It is managed with pharmaceutical and psychosocial therapies. Some medications used to treat the cognitive issues linked with the disease are acetylhocholinesterase inhibitors and mematine. Psychological interventions encompass emotion-, behavior-, cognition-, and stimulation- oriented approaches. These are used along with pharmaceutical treatment. The topics included in this book on AlzheimerÂ’s disease are of utmost significance and bound to provide incredible insights to readers. It aims to shed light on some of the unexplored aspects of evaluation and management of this disease. This book will serve as a reference to a broad spectrum of readers.

Media Books     Hardcover Book   (Book with hard spine and cover)
Released June 24, 2019
ISBN13 9781632427885
Publishers Foster Academics
Pages 222
Dimensions 203 × 276 × 14 mm   ·   752 g
Language English  

Show all

More by Blake Finn